1 Day
Source:
وكالة الأنباء القطرية
Sidra Medicine Launches First SMA Gene Therapy
Sedra Medical in Qatar has succeeded in providing the first gene therapy for spinal muscular atrophy. The treatment is a one-time injection into the cerebrospinal fluid aimed at correcting the genetic cause of the disease by introducing a healthy copy of the SMN1 gene. This achievement is significant because it makes Qatar the third country worldwide to offer this advanced therapy, highlighting the hospital's leadership in treating rare diseases. The treatment is available to eligible patients after a comprehensive evaluation by a specialized medical team.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)